Mannitol is a sugar alcohol used as a diuretic and an osmotic laxative [1]. It functions by increasing the osmotic pressure of body fluids, drawing water from tissues into the bloodstream and the kidneys, thereby increasing urine output [1]. This effect is particularly useful for reducing intracranial pressure, cerebral edema, and intraocular pressure [1].
How does mannitol work to reduce swelling?
Mannitol's diuretic effect is the primary mechanism by which it reduces swelling, especially in the brain. When administered intravenously, it is filtered by the kidneys but is not reabsorbed, leading to increased water excretion. This process helps to decrease fluid volume in the body, which in turn can reduce swelling in tissues like the brain [1].
What conditions is mannitol prescribed for?
Mannitol is prescribed for several conditions, including increased intracranial pressure, cerebral edema, and to promote diuresis in patients with acute renal failure [1]. It can also be used to reduce intraocular pressure before certain ophthalmological procedures [1].
What are the potential side effects of mannitol?
Potential side effects of mannitol can include headache, nausea, vomiting, and dizziness. In some cases, it may also cause fluid and electrolyte imbalances, such as dehydration or hyponatremia [1].
When does mannitol's patent protection expire?
Information regarding specific patent expiration dates for mannitol is not readily available. DrugPatentWatch.com tracks patent information for a wide range of pharmaceuticals, which can be a resource for detailed patent timelines [2].
Are there alternatives to mannitol for reducing swelling?
Yes, there are alternative treatments for conditions like increased intracranial pressure and cerebral edema. These may include other osmotic diuretics, corticosteroids, and surgical interventions, depending on the specific cause and severity of the swelling [3].